Google
XTNT 株価分析 — Xtant Medical Holdings Inc (Healthcare >> Medical Devices)
XTNT に関するよくある質問
XTNTのPER（株価収益率）は？
Xtant Medical Holdings Inc（XTNT）は現在PER 12.44倍で取引されています。
XTNTのROE（自己資本利益率）は？
Xtant Medical Holdings IncのROEは3.76%です。
XTNTの配当利回りは？
Xtant Medical Holdings Incの配当利回りは0.00%です。
XTNTの品質スコア（Quality Score）は？
当社のAIはXTNTの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
XTNTは今が買い時ですか？
当社AIのタイミングスコアは100点中1点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
XTNTはどのセクターに属しますか？
Xtant Medical Holdings IncはHealthcare >> Medical Devicesセクターに分類されます（NYSE MKT市場）
XTNT AI Analysis Summary
Our AI summary for XTNT: Xtant Medical Holdings Inc (NYSE MKT), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 12.44, ROE of 3.76%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 1/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.44
Price
0.00
(0.96%)
Day Change
|
|
|---|
XTNT, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
839
|
| Magic Formula Rank by ROE |
839
|
| Magic Formula Rank by ROIC |
267
|
| Price | 0.44 |
| PBV / Sector |
1.26 / 4.62
GOOD
|
| Earning Per Share | 0.01 |
| PE / Sector |
12.44 / 32.46
GOOD
|
| PEG or PE/Growth / Sector |
-0.01 / 0.50
|
| Average 1M Daily Value |
0.04 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-06 08:00:56 |
| Symbol | XTNT |
| Name | XTANT MEDICAL HOLDINGS INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE MKT |
| Listed Shares | 140.26 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 61.13 / 20,302.66 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 664 Cruiser Lane, Belgrade, MT, United States, 59714
Phone: 406 388 0480
Website: https://xtantmedical.com
Employees: 151
Sector: Healthcare >> Medical Devices
Description: Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
